Browse Category

NYSE:BSX 17 January 2026 - 29 July 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

Boston Scientific (NYSE:BSX) shares fall as international growth offsets slower U.S. cardiac performance

NEW YORK, July 29, 2026, 09:00 EDT — Boston Scientific shares declined after the medical device maker’s strong overseas results helped balance a downturn in its U.S. cardiac business.

29 July 2026

Earnings·NYSE:BSX·Stock Market·US Economy

Amazon takes number one spot on 2026 Fortune 500; regional shifts seen

Amazon has taken the No. 1 spot on the 2026 Fortune 500, Fortune said, unseating Walmart after 13 years at the top. The change put Amazon ahead for the first time in more than a decade and drove shifts in regional tallies for Pennsylvania, New Jersey and New England. Fortune’s 72nd annual list put the collective revenue at $21.0 trillion, with profits at $2.1 trillion and a workforce of 30.5 million worldwide.

15 June 2026

NASDAQ:AMZN·NASDAQ:ERIE·NYSE:BMY·NYSE:BSX·NYSE:CVS·NYSE:JNJ·NYSE:MRK·NYSE:PBF·NYSE:PRU·NYSE:TJX·NYSE:WMT·Stock Market

Boston Scientific Drops 16%. Next Up: Monday’s Watchman Reaction

Boston Scientific is starting the week trading close to its recent lows after shares dropped 16.4% last week. The selloff came as investors question if the slowdown in demand for its Watchman heart implant is temporary or a sign of a longer-term slowdown. The stock ended at $48.31 on May 29, down from $57.78 at the May 22 close, according to historical price data.

31 May 2026

NYSE:BSX·Stock Market

Boston Scientific Hits Two-Year Low After Watchman Device Warning

Boston Scientific’s stock dropped Wednesday after CEO Michael Mahoney said the company is seeing slower use of its Watchman heart device. The shares fell around 10% to $51.63 in recent trading, hitting a session low of $50.60, their lowest in over two years.

27 May 2026

Health News·NYSE:BSX·Stock Market

US Stock Market Today: Nasdaq Leads Wall Street Rally as Iran Ceasefire Relief Meets Earnings Momentum

U.S. stocks climbed Wednesday, with tech names pushing the Nasdaq higher, as investors returned to technology shares and snapped up companies posting strong earnings following President Donald Trump’s move to extend the ceasefire with Iran.

22 April 2026

Earnings Reports·Nasdaq·NASDAQ:MU·NASDAQ:STX·NYSE:BA·NYSE:BSX·Stock Market

Boston Scientific stock price slips again: BSX extends slide as heart-rhythm worries linger

Boston Scientific was off 2.6% at $74.29 as of 11:50 a.m. EST Monday, slipping from an earlier session low of $74.12. Shares dropped even as the SPDR S&P 500 ETF Trust advanced roughly 0.6%.

9 February 2026

NYSE:BSX·Stock Market

Boston Scientific stock price slips again after earnings shock as BSX investors eye heart-rhythm sales

Boston Scientific Corp finished Friday at $76.27, down 1.8%. The stock barely moved after the bell, still near its post-earnings slump from earlier this week. Roughly 34.9 million shares changed hands.

7 February 2026

Earnings Reports·NYSE:BSX·Stock Market

Boston Scientific stock rebounds after earnings shock as analysts cut targets on EP worries

Boston Scientific shares climbed 2.8% Thursday, closing at $77.64. Trading volume hit roughly 38.3 million shares.

6 February 2026

Earnings Reports·NYSE:BSX·Stock Market

Boston Scientific stock rebounds after brutal selloff — what Wall Street watches next

Boston Scientific shares climbed roughly 3.3% on Thursday, recovering some losses after a steep drop the previous day shook investors concerned about the medical device maker’s 2026 outlook. The stock traded at $77.97 in afternoon trading.

5 February 2026

NYSE:BSX·Stock Market

Boston Scientific stock tries to steady after an 18% earnings drop put EP business on edge

Boston Scientific shares ticked up roughly 1% in Thursday’s premarket, recovering some ground after a sharp slide the previous day. The stock hovered near $76.30, up from Wednesday’s $75.50 close.

5 February 2026

Earnings Reports·NYSE:BSX·Stock Market

Boston Scientific (BSX) stock dives on electrophysiology sales miss — what to watch after the bell

Shares of Boston Scientific plunged Wednesday following a disappointing sales report from its electrophysiology division, a key growth driver closely watched by investors. The stock dropped $16.23, or roughly 17.7%, to $75.50 in after-hours trading.

4 February 2026

Earnings Reports·NYSE:BSX

Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX

Boston Scientific shares dropped sharply on Wednesday, falling roughly 15% to $77.83 following a quarterly sales report that fell short of expectations in its electrophysiology segment.

4 February 2026

NYSE:BSX·Stock Market

Boston Scientific stock slips today: what to know before earnings and key Watchman trial data

Boston Scientific dipped about 0.7% to $91.20 in afternoon action Tuesday, after swinging between $93.01 and $90.85. Roughly 10.4 million shares traded.

3 February 2026

Earnings Reports·NYSE:BSX·Stock Market

Boston Scientific stock price drops today: BSX slides as investors size up Feb. 4 earnings, Watchman trial date

Boston Scientific shares dropped roughly 1.6% to $92.01 in Monday afternoon trading, bouncing between $94.13 and $91.64 earlier. The stock underperformed peers Abbott Laboratories, Medtronic Plc, and Stryker Corp., even as the S&P 500 ETF Trust climbed higher.

2 February 2026

Earnings Reports·NYSE:BSX·Stock Market

Boston Scientific stock snaps a 4-day run — what to watch before Feb. 4 earnings

Shares of Boston Scientific Corp closed Thursday roughly 1.6% lower at $92.33, having fluctuated between $91.48 and $94.25 during the session.

30 January 2026

Earnings Reports·NYSE:ABT·NYSE:BSX·NYSE:MDT·NYSE:PEN·NYSE:SYK·Stock Market

ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

Shares of Intuitive Surgical, Inc. slipped 0.7% to $525.09 Tuesday, despite a fresh U.S. approval for its newest da Vinci 5 surgical robot. Meanwhile, the broader market moved higher, with the S&P 500 ETF gaining roughly 0.5% and the Nasdaq-focused QQQ rising about 0.9%.

27 January 2026

NASDAQ:ISRG·NYSE:ABT·NYSE:BSX·NYSE:EW·Stock Market

Boston Scientific (BSX) stock ticks higher again — what to watch before Tuesday’s trade

Shares of Boston Scientific Corp climbed 1.12% to $93.55 on Monday, while the S&P 500 edged up 0.50% and the Dow Jones Industrial Average gained 0.64%. The stock underperformed Abbott Laboratories and Stryker but outpaced Medtronic. Trading volume stayed above its 50-day average. Despite Monday’s gain, shares remain roughly 14.6% below their 52-week peak from September.

27 January 2026

NYSE:BSX·Stock Market

Boston Scientific stock (BSX) climbs as heart-rhythm rivalry and deal risk stay in play

Shares of Boston Scientific Corp edged up roughly 1% to $92.20 in late afternoon trading on Friday, fluctuating earlier between $90.89 and $92.33.

23 January 2026

NYSE:BSX

Boston Scientific stock rises as BSX teases new pain-therapy data while FDA stent alert hangs over shares

Shares of Boston Scientific Corp climbed roughly 3.1% to $90.77 on Tuesday, clawing back some of last week’s losses. Investors digested new clinical data amid ongoing concerns over regulatory issues and deal rumors.

20 January 2026

Health News·NYSE:BSX·Stock Market

Boston Scientific stock price slides again as $14.5B Penumbra deal puts debt, dilution in focus

Boston Scientific Corporation shares dropped 2.18% on Friday, closing at $88.07. It marked their seventh consecutive day of declines, with volume heavier than usual. The S&P 500 slipped 0.06%, the Dow fell 0.17%, and competitors Abbott and Medtronic also finished in the red.

17 January 2026

NASDAQ:PEN·NYSE:BSX·Stock Market

1 2 Next

NYSE:BSX 17 January 2026 - 29 July 2026

Boston Scientific (NYSE:BSX) shares fall as international growth offsets slower U.S. cardiac performance

Amazon takes number one spot on 2026 Fortune 500; regional shifts seen

Boston Scientific Drops 16%. Next Up: Monday’s Watchman Reaction

Boston Scientific Hits Two-Year Low After Watchman Device Warning

US Stock Market Today: Nasdaq Leads Wall Street Rally as Iran Ceasefire Relief Meets Earnings Momentum

Boston Scientific stock price slips again: BSX extends slide as heart-rhythm worries linger

Boston Scientific stock price slips again after earnings shock as BSX investors eye heart-rhythm sales

Boston Scientific stock rebounds after earnings shock as analysts cut targets on EP worries

Boston Scientific stock rebounds after brutal selloff — what Wall Street watches next

Boston Scientific stock tries to steady after an 18% earnings drop put EP business on edge

Boston Scientific (BSX) stock dives on electrophysiology sales miss — what to watch after the bell

Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX

Boston Scientific stock slips today: what to know before earnings and key Watchman trial data

Boston Scientific stock price drops today: BSX slides as investors size up Feb. 4 earnings, Watchman trial date

Boston Scientific stock snaps a 4-day run — what to watch before Feb. 4 earnings

ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

Boston Scientific (BSX) stock ticks higher again — what to watch before Tuesday’s trade

Boston Scientific stock (BSX) climbs as heart-rhythm rivalry and deal risk stay in play

Boston Scientific stock rises as BSX teases new pain-therapy data while FDA stent alert hangs over shares

Boston Scientific stock price slides again as $14.5B Penumbra deal puts debt, dilution in focus

TechStock² Updates

Amphenol share split shifts attention to $1.9 billion order buffer

Palo Alto Networks (NASDAQ:PANW) Jumps 10% as Analysts Focus on Organic Growth

Banco Bradesco S.A. (BVMF:BBDC4) shares drop under rights issue price amid credit cost pressures

DraftKings Inc. (NASDAQ:DKNG) surges 8% as analysts say half-point margin boost could offset Q2 shortfall

SK hynix Shares Under Scrutiny Monday Amid $38 Billion Factory Move, Cash Returns in Focus

Top Stock Picks

Constellation Energy

AerCap

Walt Disney

AIG

Cheniere Energy

Live updates

Investment Disclaimer